Clinical Trial Update: SHORTness of Breath In the Emergency Department (SHORTIE) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial named SHORTIE evaluating a treatment for acute myocardial infarction, heart failure, and pulmonary embolism has completed. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction
• Pulmonary Embolism

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Acute Myocardial Infarction, Heart Failure | Phase 2, Phase 3 | Status: COMPLETED